News | May 05, 2022
JBCPL emerges as the fastest growing pharma company: Report
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
Ranked 25th with an impressive growth rate of 29% among Indian pharma companies in FY 2021-22
The data driven fertility company helps increase the success rate of fertility treatments
Brinton Pharmaceuticals enters exclusive sales and distribution rights of Scholl foot care products including Krack cream
This has further strengthened its manufacturing presence in the United States of America
Sun Pharma Advanced Research Company has reported standalone financial results for the period ended December 31, 2021
Partnering to build biosynthesis processes and a pharmaceutical production platform
The transaction is anticipated to close in the first quarter of 2022
Ectosense’s NightOwl is a leading cloud-connected home sleep apnea test
_256_384.png){kind=logo}
Results from these studies are expected to be released by 2023. If outcomes from these initial pilots are positive, the studies will be expanded to involve around 1 million participants in 2024 and 2025
At its meeting, the board also approved raising the company’s authorised share capital to Rs. 42.50 crores from Rs. 37.50 crores.
Subscribe To Our Newsletter & Stay Updated
